"Vitreous Body" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transparent, semigelatinous substance that fills the cavity behind the CRYSTALLINE LENS of the EYE and in front of the RETINA. It is contained in a thin hyaloid membrane and forms about four fifths of the optic globe.
| Descriptor ID |
D014822
|
| MeSH Number(s) |
A09.371.714.500
|
| Concept/Terms |
Vitreous Body- Vitreous Body
- Bodies, Vitreous
- Body, Vitreous
- Vitreous Bodies
- Vitreous Humor
- Humor, Vitreous
- Humors, Vitreous
- Vitreous Humors
|
Below are MeSH descriptors whose meaning is more general than "Vitreous Body".
Below are MeSH descriptors whose meaning is more specific than "Vitreous Body".
This graph shows the total number of publications written about "Vitreous Body" by people in this website by year, and whether "Vitreous Body" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2003 | 4 | 3 | 7 |
| 2004 | 4 | 0 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 3 | 3 |
| 2009 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitreous Body" by people in Profiles.
-
Lee SY, Surbeck JW, Drake M, Saunders A, Jin HD, Shah VA, Rajala RV. Increased Glial Fibrillary Acid Protein and Vimentin in Vitreous Fluid as a Biomarker for Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci. 2020 05 11; 61(5):22.
-
Legocki AT, Zepeda EM, Gillette TB, Grant LE, Shariff A, Touch P, Lee AY, Ding L, Estrada MM, Tarczy-Hornoch K, Lee CS, Mayock DE, Pepple KL, Cabrera MT. Vitreous Findings by Handheld Spectral-Domain OCT Correlate with Retinopathy of Prematurity Severity. Ophthalmol Retina. 2020 10; 4(10):1008-1015.
-
Zepeda EM, Shariff A, Gillette TB, Grant L, Ding L, Tarczy-Hornoch K, Cabrera MT. Vitreous Bands Identified by Handheld Spectral-Domain Optical Coherence Tomography Among Premature Infants. JAMA Ophthalmol. 2018 07 01; 136(7):753-758.
-
Carr BC, Emigh CE, Bennett LD, Pansick AD, Birch DG, Nguyen C. TOWARDS A TREATMENT FOR DIABETIC RETINOPATHY: Intravitreal Toxicity and Preclinical Safety Evaluation of Inducible Nitric Oxide Synthase Inhibitors. Retina. 2017 Jan; 37(1):22-31.
-
Cai X, Seal S, McGinnis JF. Sustained inhibition of neovascularization in vldlr-/- mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-?B pathway. Biomaterials. 2014 Jan; 35(1):249-58.
-
Callegan MC, Guess S, Wheatley NR, Woods DC, Griffin G, Wiskur BJ, Leonard R. Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis. Retina. 2011 Sep; 31(8):1518-24.
-
Shah VA, Reddy AK, Bonham AJ, Sabates NR, Lee AG. Resident surgical practice patterns for vitreoretinal surgery in ophthalmic training programs in the United States. Ophthalmology. 2009 Apr; 116(4):783-9.
-
Moyer AL, Ramadan RT, Novosad BD, Astley R, Callegan MC. Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3783-93.
-
Shelton L, Troilo D, Lerner MR, Gusev Y, Brackett DJ, Rada JS. Microarray analysis of choroid/RPE gene expression in marmoset eyes undergoing changes in ocular growth and refraction. Mol Vis. 2008 Aug 11; 14:1465-79.
-
Ramadan RT, Moyer AL, Callegan MC. A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest Ophthalmol Vis Sci. 2008 Oct; 49(10):4482-9.